Skip to main content

Forms of Glucocerebrosidase Present in Tissues and Urine

  • Chapter
Enzymes of Lipid Metabolism II

Abstract

Gaucher disease is a lysosomal storage disease that is characterized by accumulation of the glycosphingolipid glucocerebroside in lysosomes of cells of the reticuloendothelial system, particularly macrophages1. The metabolic basis of Gaucher disease is a deficiency of glucocerebrosidase, which catalyses the hydrolysis of glucocerebroside to glucose and ceramide2,3. Spleen is the organ that is primarily affected by storage of glucocerebroside. The β-glucosidase activities in human urine and tissues, particularly spleen, from control subjects and patients with different clinical phenotypes of Gaucher disease have been examined using a combination of biochemical and immunological methods. The results of the study are summarised in this paper.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. O. Brady and J. A. Barranger, Glucosylceramide lipidosis: Gaucher’s disease., in: “The Metabolic Basis of Inherited Disease”, J. B. Stanbury, J. B. Wijngaarden, D. S. Fredricson, J. L. Goldstein and M. S. Brown, eds., pp. 842–856, McGraw-Hill, New York (1983)

    Google Scholar 

  2. R. O. Brady, J. N. Kanfer and D. Shapiro, Metabolism of glucocerebrosides. H. Evidence of an enzymatic deficiency in Gaucher’s disease., Biochem. Biophys. Res. Commun. 18: 221 (1965)

    Article  CAS  Google Scholar 

  3. A. D. Patrick, A deficiency of glucocerebrosidase in Gaucher’s disease., Biochem. J. 97:17c-17d, p. 7 (1965)

    Google Scholar 

  4. A. Maret, R. Salvayre, A. Négre and L. Dousté-Blazy, Proprietés des formes moleculaires de la ß-glucosidases de rate humaine normale et de la maladie de Gaucher., Eur. J. Biochem. 115: 455–461 (1981)

    Article  PubMed  CAS  Google Scholar 

  5. J. M. F. G. Aerts, W. E. Donker-Koopman, M. K. Van der Vliet, L. M. V. Jonsson, E. I. Ginns, G. J. Murray, J. A. Barranger, J. M. Tager and A. W. Schram, The occurence of two immunologically distinguishable forms of glucocerebrosidases in human spleen., Eur. J. Biochem. 150: 565–574 (1985)

    Google Scholar 

  6. L. B. Daniels, P. J. Coyle, Y.-B. Chico, R. H. Glew and R. S. Labow, Purification and characterization of a cytosolic broad specificity ß-glucosidase from human liver., J. Biol. Chem. 256: 13004–13013 (1981)

    PubMed  CAS  Google Scholar 

  7. A. Maret, R. Salvayre, A. Negre and L. Dousté-Blazy, Substrate specificity of the human splenic non-specific soluble ß-glucosidase., Eur. J. Biochem. 133, 283–287 (1983)

    Article  PubMed  CAS  Google Scholar 

  8. P. G. Pentchev, B. Neumeyer, L. Svennerholm, C. G. Groth and R. O. Brady, Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher’s disease., Amer. J. Hum. Genet. 35: 621–628 (1983)

    PubMed  CAS  Google Scholar 

  9. S. P. Peters, P. Coyle, C.J. Coffee, R. H. Glew, M. S. Kuhlenschmidt, L. Rosenfeld and Y.-C. Lee, Purification and properties of a heat stable glucocerebrosidase activity factor frpm control and Gaucher spleen., J. Biol. Chem. 252: 563–573 (1977)

    PubMed  CAS  Google Scholar 

  10. E. I. Ginns, R. 0. Brady, S. Pirruccello, C. Moore, S. Sorrell, F. S. Furbish, G. J. Murray, J. M. Tager and J. A. Barranger, Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes in Gaucher disease., Proc. Natl. Acad. Sci. USA 79: 5607–5610 (1982)

    CAS  Google Scholar 

  11. A. M. Erickson, E. I. Ginns and J. A. Barranger, Biosynthesis of the lysosomal enzyme glucocerebrosidase., J. Biol. Chem. (1985) in press

    Google Scholar 

  12. J. M. Tager, J. M. F. G. Aerts, L. M. V. Jonsson, G. J. Murray, S. van Weely, A. Strijland, E. I. Ginns, J. A. Barranger and J. M. Tager, Molecular forms, biosynthesis and maturation of glucocerebrosidase, a membrane-associated lysosomal enzyme deficient in Gaucher disease., this volume.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Aerts, J.M.F.G. et al. (1986). Forms of Glucocerebrosidase Present in Tissues and Urine. In: Freysz, L., Dreyfus, H., Massarelli, R., Gatt, S. (eds) Enzymes of Lipid Metabolism II. NATO ASI Series, vol 116. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5212-9_89

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5212-9_89

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5214-3

  • Online ISBN: 978-1-4684-5212-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics